At FDA meeting, gene therapy experts wrestle with field's blindspots | BioPharma Dive

The panel suggested ways to make gene therapy research safer, but struggled to propose broader recommendations. Published Sept. 3, 2021.
https://www.google.com/url?rct=j&sa=t&url=https://www.biopharmadive.com/news/fda-gene-therapy-meeting-safety-cancer-liver/606088/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNE2iKwBWaxPiR8mefj0i3b5vpMONQ